Stockscreener 앱 받기
192.97
1.59%
-3.11
Ligand Pharmaceuticals Inc 주식(LGND)의 최신 뉴스
SG Americas Securities LLC Has $2.08 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Could Be 37% Below Their Intrinsic Value Estimate - Yahoo Finance UK
Travere, Ligand Hammered On A Surprise Delay For Their Linchpin Drug - Investor's Business Daily
Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13 - TechStock²
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap DownShould You Sell? - MarketBeat
Patterns Watch: Can Ligand Pharmaceuticals Incorporated stock continue upward trendJuly 2025 Breakouts & Safe Capital Growth Plans - Bộ Nội Vụ
Published on: 2026-01-13 22:28:13 - Bộ Nội Vụ
Ligand Pharmaceuticals (LGND) Stock Analysis: Riding on a Wave of Revenue Growth and Analyst Optimism - DirectorsTalk Interviews
Gamble on Huge Gains with These 3 Best Biotech Stocks to Buy for 2026 - Barchart.com
Can Ligand Pharmaceuticals Incorporated stock rebound after recent weaknessJuly 2025 Fed Impact & Safe Entry Zone Tips - Улправда
Will Ligand Pharmaceuticals Incorporated stock remain a Wall Street favoriteTrade Risk Assessment & Daily Risk Controlled Trade Plans - Улправда
What technical signals suggest for Ligand Pharmaceuticals Incorporated stockJuly 2025 EndofMonth & High Win Rate Trade Tips - Улправда
Is Ligand Pharmaceuticals Incorporated stock attractive for hedge fundsQuarterly Trade Report & Entry Point Confirmation Signals - ulpravda.ru
Is Ligand Pharmaceuticals Incorporated stock a top momentum playExit Point & Free Long-Term Investment Growth Plans - Улправда
Is Ligand Pharmaceuticals Incorporated (LGDN) stock positioned for digital growth eraMarket Performance Summary & Weekly High Return Opportunities - Улправда
Is Ligand Pharmaceuticals Incorporated stock positioned well for digital economyJuly 2025 Snapshot & Weekly Setup with High ROI Potential - Улправда
Risk Recap: How Ligand Pharmaceuticals Incorporated stock reacts to oil pricesMarket Trend Review & Verified Stock Trade Ideas - Улправда
Ligand Pharmaceuticals director Kozarich sells $88,532 in stock By Investing.com - Investing.com South Africa
Book value per share of Ligand Pharmaceuticals Incorporated – OTC:LGNYZ - TradingView — Track All Markets
Ligand Pharmaceuticals director Kozarich sells $88,532 in stock - Investing.com
Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells 467 Shares of Stock - MarketBeat
Moody Aldrich Partners LLC Buys Shares of 25,884 Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Calamos Advisors LLC Grows Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Tangible book value per share of Ligand Pharmaceuticals Incorporated – OTC:LGNYZ - TradingView — Track All Markets
Ligand Pharmaceuticals Earnings Notes - Trefis
Book value per share of Ligand Pharmaceuticals Incorporated – OTC:LGNZZ - TradingView — Track All Markets
Loss Report: How Ligand Pharmaceuticals Incorporated stock reacts to bond yieldsTrade Analysis Report & Daily Market Momentum Tracking - moha.gov.vn
Ligand Pharmaceuticals Incorporated $LGND Position Trimmed by Rice Hall James & Associates LLC - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Ligand Pharmaceuticals (NASDAQ:LGND) Releases FY 2025 Earnings Guidance - MarketBeat
Benefactor John Kozarich visits BC Engineering Department - Boston College
Ligand Pharmaceuticals (LGND) Price Target Increased by 24.57% to 232.69 - MSN
Ligand Pharmaceuticals IncorporatedEquity Right (LGNDZ) Price Target Increased by 23.15% to 0.01 - Nasdaq
Ligand Pharmaceuticals Incorporated $LGND Stock Holdings Increased by Congress Asset Management Co. - MarketBeat
Published on: 2025-12-20 22:34:37 - Улправда
Will Ligand Pharmaceuticals Incorporated stock continue upward momentum2025 Earnings Impact & Community Consensus Stock Picks - Улправда
How sustainable is Ligand Pharmaceuticals Incorporated stock dividend payoutJuly 2025 Action & Low Volatility Stock Recommendations - Улправда
Octavio Espinoza At Ligand Pharmaceuticals Capitalizes: Options Exercised, Resulting In $308K - Benzinga
Will Ligand Pharmaceuticals Incorporated stock deliver better than expected guidance2025 Growth vs Value & Weekly High Conviction Ideas - Улправда
[Form 4] LIGAND PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
Ligand Pharmaceuticals backs Athira Pharmas 90 million funding round - Traders Union
Published on: 2025-12-19 00:15:21 - Улправда
Why Ligand Pharmaceuticals Incorporated stock could outperform in 2025July 2025 Technicals & Proven Capital Preservation Methods - Улправда
Gains Recap: Will Ligand Pharmaceuticals Incorporated stock continue upward momentum2025 Trading Volume Trends & Safe Capital Investment Plans - Улправда
Woodstock Corp Sells 9,472 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
FY2026 Earnings Forecast for LGND Issued By Zacks Small Cap - MarketBeat
Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - Yahoo Finance
LIGAND PHARMACEUTICALS CFO Sells Shares - TradingView — Track All Markets
Ligand Pharmaceuticals (NASDAQ:LGND) CFO Sells $339,711.24 in Stock - MarketBeat
LGND: 2025 Analyst Day - Zacks Small Cap Research
Ligand Pharmaceuticals Incorporated $LGND Stock Holdings Raised by Ranger Investment Management L.P. - MarketBeat
Market Leaders: Is Ligand Pharmaceuticals Incorporated stock safe for conservative investorsPortfolio Gains Summary & Free Technical Confirmation Trade Alerts - moha.gov.vn
CFO Espinoza Files To Sell 1,804 Of Ligand Pharmaceuticals Inc [LGND] - TradingView — Track All Markets
What is HC Wainwright's Forecast for LGND FY2026 Earnings? - MarketBeat
RBC Capital Maintains Ligand Pharmaceuticals IncorporatedEquity Right (LGNDZ) Outperform Recommendation - Nasdaq
4.73%
0.92%
자본화:
|
볼륨(24시간):